yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q49657822-D66A60BF-6980-4B4E-A382-DC23E9A0C8FB
Q49657822-D66A60BF-6980-4B4E-A382-DC23E9A0C8FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49657822-D66A60BF-6980-4B4E-A382-DC23E9A0C8FB
Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines.
P2860
Q49657822-D66A60BF-6980-4B4E-A382-DC23E9A0C8FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49657822-D66A60BF-6980-4B4E-A382-DC23E9A0C8FB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
66dd7d225ab07e0d0c1374f57fb79a79d34a9d7d
P2860
Anticancer therapy with novel tubulin-interacting drugs.